Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2234440.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the lst case of neuroleptic malignant syndrome occurring in a patient receiving desipramine, a tricyclic antidepressant, with no exposure to neuroleptics. Our case suggests that this syndrome may be caused by a central imbalance between norepinephrine and dopamine, and not by dopamine depletion alone.
Medical subject headings
- Desipramine
- Neuroleptic Malignant Syndrome